Noile-Immune Biotech (TSE:4893) Ending Cash Position : 円0.0 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Ending Cash Position?

Noile-Immune Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 was 円0.0 Mil.

Noile-Immune Biotech's annual Ending Cash Position increased from Dec. 2021 (円4,140.6 Mil) to Dec. 2022 (円4,521.0 Mil) and increased from Dec. 2022 (円4,521.0 Mil) to Dec. 2023 (円5,555.7 Mil).

Noile-Immune Biotech Ending Cash Position Historical Data

The historical data trend for Noile-Immune Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Ending Cash Position Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

2,548.08

4,140.56

4,521.00

5,555.69

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial				-	-	-	-	-

Noile-Immune Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Noile-Immune Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4520.997	+	1034.694
	=	5,555.7

Noile-Immune Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.0

Noile-Immune Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines